News | March 29, 2022
Alembic Pharma acquires 100% stake in Aleor Dermaceuticals
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
Cabenuva was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen's decades-long commitment to combatting HIV
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
Voluntary nationwide recall of lots of Accuretic (quinapril HCl/hydrochlorothiazide), quinapril and hydrochlorothiazide tablets, and quinapril HCl/hydrochlorothiazide tablets due to n-nitroso- quinapril content
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Moving well beyond the traditional approach of testing a vaccine’s collective response in large populations, this precision approach can identify how an individual’s own immune system responds to a vaccine, offering an unprecedented opportunity to measure vaccine safety and effectiveness
First approved in 2019, Rinvoq is a JAK inhibitor approved for four indications across gastroenterology, dermatology and rheumatology
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
OCE+ uses IQVIA’s industry-leading data and advanced analytics to deliver AI-driven recommendations directly into the daily workflows of life sciences commercial teams
First and only once-weekly patch for convenient, well-tolerated delivery of most used drug for the treatment of Alzheimer's-related dementia
Subscribe To Our Newsletter & Stay Updated
